| scholarly article | Q13442814 |
| P50 | author | Charlene S Dezzutti | Q55298106 |
| Robert W Buckheit | Q114435506 | ||
| P2093 | author name string | David F Katz | |
| Jennifer J Peters | |||
| Karen W Buckheit | |||
| Anthony S Ham | |||
| Sean T Nugent | |||
| Ashlee D Boczar | |||
| Cory M Shelter | |||
| P2860 | cites work | Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity | Q21133918 |
| Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel | Q24544056 | ||
| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women | Q24629582 | ||
| Global epidemiology of HIV infection in men who have sex with men | Q28271559 | ||
| Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide | Q28378796 | ||
| In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide | Q28472968 | ||
| Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation | Q28540761 | ||
| Preexposure prophylaxis for HIV infection among African women | Q29620077 | ||
| Assessing microbicide acceptability: a comprehensive and integrated approach. | Q30362581 | ||
| Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection | Q30411459 | ||
| Tenofovir-based preexposure prophylaxis for HIV infection among African women | Q30621914 | ||
| Vaginal deployment and tenofovir delivery by microbicide gels | Q30647900 | ||
| A vaginal fluid simulant | Q33653706 | ||
| Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. | Q33833859 | ||
| Per-contact risk of human immunodeficiency virus transmission between male sexual partners | Q33869711 | ||
| Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro | Q34025707 | ||
| A review of the physical and chemical properties of human semen and the formulation of a semen simulant | Q34426459 | ||
| Order of orifices: sequence of condom use and ejaculation by orifice during anal intercourse among women: implications for HIV transmission | Q34440636 | ||
| Heterosexual anal intercourse among community and clinical settings in Cape Town, South Africa | Q34472243 | ||
| Rectal microbicide development. | Q34575590 | ||
| The increase in global HIV epidemics in MSM. | Q34654072 | ||
| A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007). | Q34661892 | ||
| Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations | Q34704317 | ||
| Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. | Q34737582 | ||
| Women's anal sex practices: implications for formulation and promotion of a rectal microbicide | Q34773756 | ||
| Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004) | Q35012567 | ||
| Rectal microbicides: can we make them and will people use them? | Q35012572 | ||
| Effects of sodium concentration and osmolality on water and electrolyte absorption from the intact human colon | Q35571754 | ||
| The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk | Q35629984 | ||
| AIDS in America--forgotten but not gone | Q36057723 | ||
| Reformulated tenofovir gel for use as a dual compartment microbicide. | Q36159765 | ||
| RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate | Q36359092 | ||
| Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay | Q36803970 | ||
| Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. | Q37159238 | ||
| Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States | Q37249738 | ||
| The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors | Q40042904 | ||
| Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2. | Q40060575 | ||
| Heterosexual anal intercourse increases risk of HIV infection among young South African men. | Q46253583 | ||
| Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. | Q51170392 | ||
| Rectal microbicide acceptability: results of a volume escalation trial. | Q65002886 | ||
| A study on the buffering activity of the human rectum. In vivo demonstration of HCO3- and H+ secretion after rectal application of fluids with an unphysiological pH | Q69341892 | ||
| Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission | Q79687951 | ||
| Permeability of tritiated water through human cervical and vaginal tissue | Q80289918 | ||
| In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials | Q81352536 | ||
| Sexual lubricants in South Africa may potentially disrupt mucosal surfaces and increase HIV transmission risk among men who have sex with men | Q87032013 | ||
| P921 | main subject | prevention of HIV/AIDS | Q7242372 |
| P304 | page(s) | 153-164 | |
| P577 | publication date | 2015-06-17 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention | |
| P478 | volume | 120 |
| Q38775728 | Coupled gel spreading and diffusive transport models describing microbicidal drug delivery. |
| Q60909800 | Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood |
| Q53751650 | Designing and developing suppository formulations for anti-HIV drug delivery. |
| Q64137772 | Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques |
| Q59359510 | Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review |
| Q36257669 | Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema |
| Q39356290 | On-demand microbicide products: design matters |
| Q36644657 | Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques |
| Q37023114 | Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis |
| Q38802457 | Stimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activity. |
Search more.